SAM
BMY icon

S.A. Mason’s Bristol-Myers Squibb BMY Stock Holding History

S.A. Mason’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$222K Buy
3,667
+51
+1% +$2.97K 0.08% 192
2025
Q4 		$195K Buy
3,616
+3
+0.1% +$144 0.08% 194
2025
Q3 		$163K Buy
3,613
+2
+0.1% +$93 0.07% 202
2025
Q2 		$167K Sell
3,611
-498
-12% -$24.4K 0.08% 185
2025
Q1 		$251K Buy
4,109
+181
+5% +$10.6K 0.13% 148
2024
Q4 		$222K Sell
3,928
-158
-4% -$8.83K 0.12% 161
2024
Q3 		$211K Buy
4,086
+2
+0% +$94 0.11% 163
2024
Q2 		$170K Buy
4,084
+2
+0% +$89 0.1% 172
2024
Q1 		$221K Buy
4,082
+152
+4% +$7.74K 0.13% 147
2023
Q4 		$202K Sell
3,930
-999
-20% -$52.4K 0.14% 151
2023
Q3 		$286K Sell
4,929
-331
-6% -$20.3K 0.21% 120
2023
Q2 		$365K Hold
5,260
– – 0.26% 103
2023
Q1 		$365K Sell
5,260
-129
-2% -$9.1K 0.26% 103
2022
Q4 		$388K Sell
5,389
-185
-3% -$13.9K 0.29% 95
2022
Q3 		$396K Buy
5,574
+1
+0% +$73 0.31% 89
2022
Q2 		$429K Buy
5,573
+50
+0.9% +$3.81K 0.31% 92
2022
Q1 		$403K Buy
5,523
+501
+10% +$33.6K 0.25% 103
2021
Q4 		$313K Buy
5,022
+1
+0% +$59 0.19% 125
2021
Q3 		$297K Buy
5,021
+1
+0% +$66 0.2% 129
2021
Q2 		$335K Buy
5,020
+1
+0% +$65 0.23% 119
2021
Q1 		$317K Buy
5,019
+301
+6% +$18.7K 0.24% 114
2020
Q4 		$293K Buy
4,718
+1
+0% +$61 0.24% 110
2020
Q3 		$284K Sell
4,717
-7
-0.1% -$421 0.27% 99
2020
Q2 		$278K Buy
4,724
+1
+0% +$60 0.29% 95
2020
Q1 		$263K Buy
4,723
+109
+2% +$6.66K 0.32% 92
2019
Q4 		$296K Buy
+4,614
New +$264K 0.28% 101

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

S.A. Mason's BMY Position: Q1 2026 in Review

S.A. Mason increased its Bristol-Myers Squibb (BMY) stake by 1.4% in Q1 2026, buying an estimated $2.97K and bringing the position to 3,667 shares worth $222K. The position accounts for 0.08% of the portfolio, ranked #192.

S.A. Mason first reported a position in BMY in Q4 2019 and has held it in 26 quarters since. The position peaked at $429K in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • S.A. Mason held 3,667 shares of Bristol-Myers Squibb worth $222K as of Q1 2026.
  • S.A. Mason bought 51 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.97K.
  • Bristol-Myers Squibb made up 0.08% of S.A. Mason's portfolio in Q1 2026, its #192 holding.
  • S.A. Mason first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 26 quarters since.
  • S.A. Mason's Bristol-Myers Squibb position peaked at $429K in Q2 2022.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on S.A. Mason's 13F filing for Q1 2026, filed 27 Apr 2026.